Effectively reduce diabetic brain complications
An exciting new development at the University of Nebraska Medical Center helps mitigate the disastrous effects of diabetes—particularly degenerative and destructive brain complications more often seen in the elderly.
Research on diabetic animals show that an enzyme, Glyoxalase-1, could be used to treat common diabetes complications such as blindness, heart disease, kidney failure, and erectile dysfunction.
Even more promising, the therapy also helps improve brain function and minimizes the amount of brain tissue affected by a stroke, all while significantly helping reduce blood sugar levels.
Glyoxalase-1 targets and degrades the suspected cause of these complications—a naturally occurring chemical, methylglyoxal, which is created by damaged cells when blood sugar levels are high.
Currently there are no FDA-approved treatments that target brain complications in diabetes and also help manage blood sugar levels. But with a committed partnership, Glyoxalase-1 could be the first.
To discuss licensing opportunities please contact Catherine Murari-Kanti, Ph.D., at firstname.lastname@example.org or 402-559-3265.